ALBANY, N.Y., Aug. 15, 2013 /PRNewswire/ -- AMRI (NASDAQ: AMRI), a leading contract research and manufacturing organization, announces receipt of the 2013 CMO Leadership Award for distinction in Quality from Life Science Leader, an industry-focused news publication. The award acknowledges the survey results of more than 10,000 pharmaceutical and biotechnology executives based on research conducted by Nice Insight. The survey covered more than 100 contract manufacturing organizations (CMOs). AMRI was selected as an award winner in the category of quality, which is generally defined "as a business that will treat a customer's project as if it was its own."
The Life Science Leader annual CMO Leadership Awards will be highlighted and detailed in the publication's annual CMO Leadership Awards supplement, published to coincide with the 2013 AAPS Convention in October 2013. Life Science Leader will formally present the 2013 CMO Leadership Awards at a ceremony and industry gathering in New York City on March 12, 2014.
Thomas E. D'Ambra, Ph.D., President and CEO, AMRI, said, "Quality, commitment to purpose and customer satisfaction and service are important AMRI core values that are part of our culture that we live by. To be recognized by our industry peers and customers as a leading CMO in the area of quality is a great honor and testament to the dedication of my colleagues at AMRI to each and every customer. We are grateful that our customers recognize AMRI SMARTSOURCING™ as a high quality global brand, and we will continue to search for ways to improve our offerings and performance."
About AMRIAlbany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 21 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING ™, a full range of value-added opportunities providing customers with informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at http://www.amriglobal.com or follow us on Twitter ( @amriglobal). SOURCE AMRI
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV